Abstract:This work focuses on the δ receptor (DOR), a G protein-coupled receptor (GPCR) belonging to the opioid receptor group. DOR is expressed in numerous tissues, particularly within the nervous system. Our study explores computationally the receptor's interactions with various ligands, including opiates and opioid peptides. It elucidates how these interactions influence the δ receptor response, relevant in a wide range of health and pathological processes. Thus, our investigation aims to explore the significance of DOR as an incoming drug target for pain relief and neurodegenerative diseases and as a source for novel opioid non-narcotic analgesic alternatives. We analyze the receptor's structural properties and interactions using Molecular Dynamics (MD) simulations and Gaussian-accelerated MD across different functional states. To thoroughly assess the primary differences in the structural and conformational ensembles across our different simulated systems, we initiated our study with 1 μs of conventional Molecular Dynamics. The strategy was chosen to encompass the full activation cycle of GPCRs, as activation processes typically occur within this microsecond range. Following the cMD, we extended our study with an additional 100 ns of Gaussian accelerated Molecular Dynamics (GaMD) to enhance the sampling of conformational states. This simulation approach allowed us to capture a comprehensive range of dynamic interactions and conformational changes that are crucial for GPCR activation as influenced by different ligands. Our study includes comparing agonist and antagonist complexes to uncover the collective patterns of their functional states, regarding activation, blocking, and inactivation of DOR, starting from experimental data. In addition, we also explored interactions between agonist and antagonist molecules from opiate and opioid classifications to establish robust structure-activity relationships. These interactions have been systematically quantified using a Quantitative Structure-Activity Relationships (QSAR) model. This research significantly contributes to our understanding of this significant pharmacological target, which is emerging as an attractive subject for drug development.

Trafficking of Central Opioid Receptors and Descending Pain Inhibition.

Nerve Growth Factor-Regulated Emergence Of Functional Delta-Opioid Receptors

Signaling Cascades for Δ-Opioid Receptor-Mediated Inhibition of GABA Synaptic Transmission and Behavioral Antinociception

Activation of delta opioid receptors induces receptor insertion and neuropeptide secretion.

Interaction with Vesicle Luminal Protachykinin Regulates Surface Expression of Δ-Opioid Receptors and Opioid Analgesia

Receptor Trafficking Induced by Mu-Opioid-Receptor Phosphorylation

Synaptic mechanism for functional synergism between delta- and mu-opioid receptors.

Synaptic Mechanism for Functional Synergism Between Δ- and Μ-Opioid Receptors

Rewarding Morphine-Induced Synaptic Function of Δ-Opioid Receptors on Central Glutamate Synapses

Delta opioid receptor activation modulates affective pain and modality‐specific pain hypersensitivity associated with chronic neuropathic pain

Δ-Opioid Receptor Induced Inhibition of Sodium Channel Function

Delta opioid receptors in brain function and diseases

Coexpression of Delta- and Mu-Opioid Receptors in Nociceptive Sensory Neurons

Descriptive molecular pharmacology of the δ opioid receptor (DOR): A computational study with structural approach

Facilitation of μ-opioid receptor activity by preventing δ-opioid receptor-mediated codegradation.

The mechanism of μ-opioid receptor (MOR)-TRPV1 crosstalk in TRPV1 activation involves morphine anti-nociception, tolerance and dependence

Pharmacological traits of delta opioid receptors: pitfalls or opportunities?

The Mechanism Of Mu-Opioid Receptor (Mor)-Trpv1 Crosstalk In Trpv1 Activation Involves Morphine Anti-Nociception, Tolerance And Dependence

The role of orphan G protein-coupled receptors in pain

An engineered trafficking biosensor reveals a role for DNAJC13 in DOR downregulation

Delta opioid receptor regulation of CGRP dynamics in the trigeminal complex